Autolus Therapeutics (AUTL) Receivables (2021 - 2025)
Historic Receivables for Autolus Therapeutics (AUTL) over the last 5 years, with Q3 2025 value amounting to $33.5 million.
- Autolus Therapeutics' Receivables rose 550869.57% to $33.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year increase of 550869.57%. This contributed to the annual value of $1.4 million for FY2024, which is 12976.0% up from last year.
- Latest data reveals that Autolus Therapeutics reported Receivables of $33.5 million as of Q3 2025, which was up 550869.57% from $27.3 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Receivables high stood at $33.5 million for Q3 2025, and its period low was $384000.0 during Q4 2021.
- In the last 5 years, Autolus Therapeutics' Receivables had a median value of $1.4 million in 2024 and averaged $7.7 million.
- Per our database at Business Quant, Autolus Therapeutics' Receivables tumbled by 7628.87% in 2024 and then surged by 550869.57% in 2025.
- Autolus Therapeutics' Receivables (Quarter) stood at $384000.0 in 2021, then skyrocketed by 305.21% to $1.6 million in 2022, then crashed by 59.83% to $625000.0 in 2023, then surged by 129.76% to $1.4 million in 2024, then surged by 2235.65% to $33.5 million in 2025.
- Its last three reported values are $33.5 million in Q3 2025, $27.3 million for Q2 2025, and $14.7 million during Q1 2025.